Citation Impact
Citing Papers
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Vitamin D Deficiency and Risk of Cardiovascular Disease
2008 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney
2006 StandoutNobel
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Neural regulation of hypoxia-inducible factors and redox state drives the pathogenesis of hypertension in a rodent model of sleep apnea
2015 StandoutNobel
Reno-protective effects of renin–angiotensin system blockade in type 2 diabetic patients: a systematic review and network meta-analysis
2011
A comparison of urinary albumin excretion rate and microalbuminuria in various glucose tolerance subjects
2005
Resistant Hypertension
2008
Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study
2009 Standout
The role of JAK/STAT signaling pathway and its inhibitors in diseases
2020
Complications of Type 1 Diabetes
2010
Prevalence of the metabolic syndrome in patients with coronary heart disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm
2004
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
2006 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Type I interferon blockade in systemic lupus erythematosus: where do we stand?
2013
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
2007 Standout
Systemic lupus erythematosus
2016
Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension
2010 Standout
Rejection of the Kidney Allograft
2010
The metabolic syndrome
2010 Standout
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Renal Gene and Protein Expression Signatures for Prediction of Kidney Disease Progression
2009
Complement-Binding Anti-HLA Antibodies and Kidney-Allograft Survival
2013 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study
2017 Standout
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
The Potency of Team-Based Care Interventions for Hypertension
2009
Diabetes in Asia
2009 Standout
The metabolic syndrome
2005 Standout
The Kidney, Hypertension, and Remaining Challenges
2009
US Trends in Prevalence, Awareness, Treatment, and Control of Hypertension, 1988-2008
2010 Standout
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Treatment of Hypertension in Patients 80 Years of Age or Older
2008 Standout
Current jakinibs for the treatment of rheumatoid arthritis: a systematic review
2021
Type 1 diabetes
2013 Standout
The effect of antihypertensive agents on sleep apnea: protocol for a randomized controlled trial
2014
Alzheimer's Disease
2010 Standout
Ferroptosis: mechanisms, biology and role in disease
2021 Standout
Ferroptosis and Necroptosis in the Kidney
2020
Chronic Kidney Disease
2016 Standout
Physician Competencies for Prescribing Lifestyle Medicine
2010 Standout
Molecular Regulation of Vascular Smooth Muscle Cell Differentiation in Development and Disease
2004 Standout
Drug-induced atrioventricular block: prognosis after discontinuation of the culprit drug
2004
Prediction of Cardiovascular Events and All-Cause Mortality With Arterial Stiffness
2010 Standout
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
2017 Standout
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Pharmacokinetics and Safety of a Single Oral Dose of Peficitinib (ASP015K) in Japanese Subjects With Normal and Impaired Hepatic Function
2019
Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss
2005 Standout
AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update
2006 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial
2010 Standout
Strain-Specific Manifestation of Lupus-like Systemic Autoimmunity Caused by Zap70 Mutation
2019 StandoutNobel
Targeting the JAK/STAT pathway in solid tumors
2020
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
Efficacy and Safety of PF‐06651600 (Ritlecitinib), a Novel JAK3/TEC Inhibitor, in Patients With Moderate‐to‐Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate
2020
Decision aids for people facing health treatment or screening decisions
2017 Standout
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease
2011
Resistant Hypertension: Diagnosis, Evaluation, and Treatment
2008
Nowy rok, stare problemy, ale i nowe możliwości
2014 Standout
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Janus kinase inhibitors: A therapeutic strategy for cancer and autoimmune diseases
2020
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Mechanisms of Diabetic Complications
2013 Standout
Obstructive Sleep Apnea
2011
MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial
2003 Standout
Peficitinib: First Global Approval
2019
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification
2003 Standout
Recommendations for Blood Pressure Measurement in Humans and Experimental Animals
2005 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Resistant Hypertension: Diagnosis, Evaluation, and Treatment
2008 Standout
Works of Jay Garg being referenced
Thiazide Diuretics, Potassium, and the Development of Diabetes
2006
Resistant Hypertension Revisited: A Comparison of Two University-Based Cohorts
2005
Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study
2012
A Phase I/II Randomized Open-Label Multicenter Trial of Efalizumab, a Humanized Anti-CD11a, Anti-LFA-1 in Renal Transplantation
2007
Targeting Cell Death Pathways for Therapeutic Intervention in Kidney Diseases
2016
Angiotensin Receptor Blockade and Arterial Compliance in Chronic Kidney Disease: A Pilot Study
2005
Drug Interactions Between Peficitinib, an Orally Administered, Once-Daily Janus Kinase Inhibitor, and Rosuvastatin in Healthy Subjects
2016
Evaluation and Treatment of Patients With Systemic Hypertension
2002
The Effect of Verapamil, a P‐Glycoprotein Inhibitor, on the Pharmacokinetics of Peficitinib, an Orally Administered, Once‐Daily JAK Inhibitor
2017
Peficitinib, a JAK Inhibitor, in the Treatment of Moderate‐to‐Severe Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate
2016
Peficitinib, a JAK Inhibitor, in Combination With Limited Conventional Synthetic Disease‐Modifying Antirheumatic Drugs in the Treatment of Moderate‐to‐Severe Rheumatoid Arthritis
2017
Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease
2002